| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |